Carta Circular MC21-077-CG | FDA Requests Removal Strongest Warning Using Cholesterol-lowering Statins during Pregnancy


Circular Letter MC21-077-CG
FDA Requests Removal Strongest Warning Using Cholesterol-lowering Statins during Pregnancy